NEW YORK, NY--(Marketwire - July 14, 2008) - Pink OTC Markets Inc., the leading electronic inter-dealer quotation system, trading technology and financial information provider for over-the-counter (OTC) securities, today announced that ReGen Therapeutics (PINKSHEETS: REGUY) (OTCQX: REGUY), a pharmaceutical company engaged in the development of drugs for Alzheimer’s disease and other neurological diseases and conditions, has chosen to list its American Depositary Receipts (ADR) on International OTCQX.
